Filing Details

Accession Number:
0001104659-25-014027
Form Type:
13G Filing
Publication Date:
2025-02-13 19:00:00
Filed By:
Ridgeback Capital Management
Company:
Pyxis Oncology Inc.
Filing Date:
2025-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Ridgeback Capital Investments L.P. 0 359,231 0.6%
Ridgeback Capital Investments LLC 0 359,231 0.6%
Ridgeback Capital Management LLC 0 359,231 0.6%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Ridgeback Capital Investments L.P.
 
Signature:/s/ Nicole Venezia
Name/Title:Nicole Venezia/General Counsel
Date:02/14/2025
 
Ridgeback Capital Investments LLC
 
Signature:/s/ Nicole Venezia
Name/Title:Nicole Venezia/General Counsel
Date:02/14/2025
 
Ridgeback Capital Management LLC
 
Signature:/s/ Nicole Venezia
Name/Title:Nicole Venezia/General Counsel
Date:02/14/2025
Exhibit Information

Exhibit Number 99.1 (previously filed) - Joint Filing Agreement